Nautilus Biotechnology (NAUT) Other Non Operating Income (2021 - 2023)
Nautilus Biotechnology (NAUT) reported Other Non Operating Income of -$14000.0 for Q2 2023, down 300.0% on a YoY basis from $7000.0 in Q2 2022, and up 89.39% sequentially from -$132000.0 in Q3 2022.
Nautilus Biotechnology (NAUT) Other Non Operating Income (2021 - 2023) Analysis & Trends
Nautilus Biotechnology (NAUT) has 3 years of Other Non Operating Income data on file, last reported at -$14000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nautilus Biotechnology | 224.14 Mn | 224.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -14,000.00 |
| Sep 30, 2022 | -132,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Sep 30, 2021 | -72,000.00 |